Oxygen therapy use in older adults with chronic obstructive pulmonary disease

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Nishi, Shawn P E ^a   Zhang, Wei ^a   Kuo, Yong Fang ^b   Sharma, Gulshan ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN;

ADULT; AGED; ARTICLE; CAUCASIAN; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; FEMALE; HOSPITALIZATION; HUMAN; MALE; MEDICARE; OXYGEN THERAPY; RETROSPECTIVE STUDY; SEX DIFFERENCE; SOCIAL STATUS; UNITED STATES; VERY ELDERLY; ECONOMICS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; UTILIZATION;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MEDICARE; OXYGEN INHALATION THERAPY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84925440722     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0120684     Document Type: Article

References (38)

1. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med, 1980. 93(3): p. 391-8. PMID: 6776858
2. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet, 1981. 1(8222): p. 681-6. PMID: 6110912
3. Zieliński J, Tobiasz M, Hawryłkiewicz I, Sliwiński P, Pałasiewicz G. Effects of long-term oxygen therapy on pulmonary hemodynamics in COPD patients: a 6-year prospective study. Chest, 1998. 113(1): p. 65-70. PMID: 9440570
4. Borak J, Sliwiński P, Tobiasz M, Górecka D, Zieliński J. Psychological status of COPD patients before and after one year of long-term oxygen therapy. Monaldi Arch Chest Dis, 1996. 51(1): p. 7-11. PMID: 8901313
5. New problems in supply, reimbursement and certification of medical necessity for long-term oxygen therapy., in American review of respiratory disease 1990. p. 721-724.
6. MEDICARE HOME OXYGEN: Refining Payment Methodology Has Potential to Lower Program and Beneficiary Spending. 2011.
7. Medicare Coverage Database, MCD Chapter 240.2. Available: www.cms.hhs.gov. Accessed: 2013 Apr 11.
8. th long-term oxygen therapy consensus conference. Respir Care, 2006. 51(5): p. 519-25. PMID: 16710952
9. Global Strategy for Diagnosis, Management, and Prevention of COPD. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2014 January 2014. Available: http://www.goldcopd.org/uploads/users/files/GOLD-Report-2014-Jan23.pdf. Accessed: 2014 May 15.
10. Mannino DM, Braman S. The epidemiology and economics of chronic obstructive pulmonary disease. Proc Am Thorac Soc, 2007. 4(7): p. 502-6. PMID: 17878461
11. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care, 1998. 36(1): p. 8-27. PMID: 9431328
12. Medicare data file descriptions. Available: www.resdac.umb.edu/Medicare/file-descritions.asp. Accessed: 2013 Jan 24.
13. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance - United States, 1971-2000. MMWR Surveill Summ, 2002. 51(6): p. 1-16. PMID: 12198919
14. Suh DC, Lau H, Pokras SM, Choi IS, Valiyeva E. Sex differences in ambulatory visits for chronic obstructive pulmonary disease, based on the National Ambulatory Medical Care Survey and the National Hospital Ambulatory Medical Care Survey from 1995 to 2004. Respir Care, 2008. 53(11): p. 1461-9. PMID: 18957148
15. Akinmabi LJ, Liu X. Chronic Obstructive Pulmonary Disease Among Adults Aged 18 and Over in the United States, 1998-2009, Brief N.D., Editor. June 2011, Centers for Disease Control and Prevention. doi: 10.7556/jaoa.2013.045 PMID: 24084802
16. Ringbaek TJ, Lange P. Trends in long-term oxygen therapy for COPD in Denmark from 2001 to 2010. Respir Med, 2013.
17. Behavioural Risk Factor Surveillance - United States, 2011, C.f.D.C.a.P.U.S.D.o.H.a.H. Services., Editor., American Lung Association Research and Health Education.
18. Xu X, Li B, Wang L. Gender difference in smoking effects on adult pulmonary function. Eur Respir J, 1994. 7(3): p. 477-83. PMID: 8013605
19. Prescott E, Bjerg AM, Andersen PK, Lange P, Vestbo J. Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur Respir J, 1997. 10(4): p. 822-7. PMID: 9150319
20. Langhammer A, Johnsen R, Gulsvik A, Holmen TL, Bjermer L. Sex differences in lung vulnerability to tobacco smoking. Eur Respir J, 2003. 21(6): p. 1017-23. PMID: 12797498
21. Chapman KR. Chronic obstructive pulmonary disease: are women more susceptible than men? Clin Chest Med, 2004. 25(2): p. 331-41. PMID: 15099893
22. Dransfield MT, Davis JJ, Gerald LB, Bailey WC. Racial and gender differences in susceptibility to tobacco smoke among patients with chronic obstructive pulmonary disease. Respir Med, 2006. 100(6): p. 1110-6. PMID: 16236491
23. Akpunonu B, Mutgi A, Federman D, Donabedian H, Wasielewski N, Lachant M, et al. Inappropriate use of oxygen: loss of a valuable healthcare resource. Am J Med Sci, 1994. 308(4): p. 244-6. PMID: 7942984
24. Morrison D, Skwarski K, MacNee W. Review of the prescription of domiciliary long term oxygen therapy in Scotland. Thorax, 1995. 50(10): p. 1103-5. PMID: 7491562
25. Oba Y, Salzman GA, Willsie SK. Reevaluation of continuous oxygen therapy after initial prescription in patients with chronic obstructive pulmonary disease. Respir Care, 2000. 45(4): p. 401-6. PMID: 10780035
26. Ringbaek TJ, Lange P. The impact of the Danish Oxygen Register on adherence to guidelines for longterm oxygen therapy in COPD patients. Respir Med, 2006. 100(2): p. 218-25. PMID: 15932796
27. Ström K, Boe J, Boman G, Midgren B, Rosenhall L. Long-term domiciliary oxygen therapy. Experiences acquired from the Swedish Oxygen Register. Monaldi Arch Chest Dis, 1993. 48(5): p. 473-8. PMID: 8312907
28. Guyatt GH, McKim DA, Austin P, Bryan R, Norgren J, Weaver B, et al. Appropriateness of domiciliary oxygen delivery. Chest, 2000. 118(5): p. 1303-8. PMID: 11083678
29. Chaney JC, Jones K, Grathwohl K, Olivier KN. Implementation of an oxygen therapy clinic to manage users of long-term oxygen therapy. Chest, 2002. 122(5): p. 1661-7. PMID: 12426268
30. Wisely C. Five Things Physicians and Patients Should Question. 2013 Available: http://www.choosingwisely.org/doctor-patient-lists/american-college-of-chest-physicians-and-american-thoracicsociety/. Accessed: 2014 May 15.
31. Deficit Reduction Act, in 42 USC 1395m(a)(5) §5101 (b), Pub L No. 109-171 amended.
32. Details for: EXPANSION OF COMPETITIVE BIDDING PROGRAM WILL INCREASE COMPETITION, MAINTAIN QUALITY, AND SAVE MEDICARE BILLIONS. Jan 2013.
33. Johnston K, Grimmer-Somers K. Pulmonary rehabilitation: overwhelming evidence but lost in translation? Physiother Can, 2010. 62(4): p. 368-73. doi: 10.3138/physio.62.4.368 PMID: 21886377
34. Keating A, Lee A, Holland AE. What prevents people with chronic obstructive pulmonary disease from attending pulmonary rehabilitation? A systematic review. Chron Respir Dis, 2011. 8(2): p. 89-99. doi: 10.1177/1479972310393756 PMID: 21596892
35. Hayton C, Clark A, Olive S, Browne P, Galey P, Knights E. Barriers to pulmonary rehabilitation: characteristics that predict patient attendance and adherence. Respir Med, 2013. 107(3): p. 401-7. doi: 10.1016/j.rmed.2012.11.016 PMID: 23261311
36. O'Donohue WJ Jr, Plummer AL. Magnitude of usage and cost of home oxygen therapy in the United States. Chest, 1995. 107(2): p. 301-2. PMID: 7842750
37. Han MK, Kim MG, Mardon R, Renner P, Sullivan S, Diette GB. Spirometry utilization for COPD: how do we measure up? Chest, 2007. 132(2): p. 403-9. PMID: 17550936
38. Mularski RA, Asch SM, Shrank WH, Kerr EA, Setodji CM, Adams JL. The quality of obstructive lung disease care for adults in the United States as measured by adherence to recommended processes. Chest, 2006. 130(6): p. 1844-50. PMID: 17167007